246 related articles for article (PubMed ID: 30590814)
1. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
Zhi T; Jiang K; Xu X; Yu T; Zhou F; Wang Y; Liu N; Zhang J
Neuro Oncol; 2019 Mar; 21(4):462-473. PubMed ID: 30590814
[TBL] [Abstract][Full Text] [Related]
2. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
3. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG16 contributes to glioma malignancy by competitively binding miR-20a-5p with E2F1.
Yang BY; Meng Q; Sun Y; Gao L; Yang JX
J Biol Regul Homeost Agents; 2018; 32(2):251-261. PubMed ID: 29685003
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
[TBL] [Abstract][Full Text] [Related]
6. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
7. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
[TBL] [Abstract][Full Text] [Related]
8. Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells.
Cui L; Ren T; Zhao H; Chen S; Zheng M; Gao X; Feng D; Yang L; Jin X; Zhuo R
Med Oncol; 2020 Jul; 37(8):73. PubMed ID: 32725378
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
[TBL] [Abstract][Full Text] [Related]
10. Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization.
Yokoyama S; Iwakami Y; Hang Z; Kin R; Zhou Y; Yasuta Y; Takahashi A; Hayakawa Y; Sakurai H
Sci Rep; 2020 Nov; 10(1):19214. PubMed ID: 33154524
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.
Zhu R; Liu Y; Zhou H; Li L; Li Y; Ding F; Cao X; Liu Z
Cancer Lett; 2018 Apr; 418():125-134. PubMed ID: 29331416
[TBL] [Abstract][Full Text] [Related]
12. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1.
Li J; Li Y; Xu F; Sun B; Yang L; Wang H
Exp Cell Res; 2022 Jun; 415(2):113148. PubMed ID: 35405117
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
15. Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.
Zhou X; Xie S; Wu S; Qi Y; Wang Z; Zhang H; Lu D; Wang X; Dong Y; Liu G; Yang D; Shi Q; Bian W; Yu R
Neuro Oncol; 2017 Nov; 19(12):1628-1639. PubMed ID: 28575494
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene expression and activate lung epithelial cells.
Wang D; Zhao J; Li S; Wei J; Nan L; Mallampalli RK; Weathington NM; Ma H; Zhao Y
J Mol Cell Biol; 2018 Feb; 10(1):60-73. PubMed ID: 28992046
[TBL] [Abstract][Full Text] [Related]
17. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1.
Sun JY; Xiao WZ; Wang F; Wang YQ; Zhu YH; Wu YF; Miao ZL; Lin YC
Mol Med Rep; 2015 Aug; 12(2):2355-9. PubMed ID: 25901521
[TBL] [Abstract][Full Text] [Related]
19. Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1.
Chuang TY; Min J; Wu HL; McCrary C; Layman LC; Diamond MP; Azziz R; Al-Hendy A; Chen YH
Reprod Sci; 2017 Jul; 24(7):1005-1013. PubMed ID: 27799459
[TBL] [Abstract][Full Text] [Related]
20. Alteration of Pituitary Tumor Transforming Gene-1 Regulates Trophoblast Invasion via the Integrin/Rho-Family Signaling Pathway.
Lim SM; Jang HY; Lee JE; Shin JS; Park SH; Yoon BH; Kim GJ
PLoS One; 2016; 11(2):e0149371. PubMed ID: 26900962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
